• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物治疗痉挛。

Managing spasticity with drugs.

机构信息

Physical Medicine and Rehabilitation Department, AP-HP, GH Bichat, University Paris7, Paris, France.

出版信息

Eur J Phys Rehabil Med. 2010 Sep;46(3):401-10.

PMID:20927006
Abstract

Spasticity is a common symptom observed after pyramidal system lesion. The treatment of spasticity has considerably changed during last years, notably with the generalization of Botulinum toxin use. However, the treatment of spasticity should consider all therapeutic possibility in accordance with patient status and objective. Drugs are only a part of the treatment and physical therapy must always be used. Others treatments such as surgery, orthosis, occupational therapy must also be discussed individually. Several guidelines are now available for Botulinum toxin treatment but only the French guidelines consider all drug therapies. This review addresses the different drugs commonly used on the basis of an extensive review of literature. Some facts are clearly established by randomized controlled trials but a certain number of questions remains unclear and only clinical experience and consensus can guide injectors.

摘要

痉挛是锥体系统损伤后常见的症状。近年来,痉挛的治疗发生了很大的变化,特别是肉毒毒素的广泛应用。然而,痉挛的治疗应根据患者的状况和客观情况考虑所有的治疗可能性。药物只是治疗的一部分,物理治疗必须始终使用。其他治疗方法,如手术、矫形器、职业治疗也必须单独讨论。目前有几个关于肉毒毒素治疗的指南,但只有法国指南考虑了所有的药物治疗。这篇综述根据文献的广泛回顾,讨论了常用的不同药物。一些事实已经通过随机对照试验得到明确确立,但仍有一些问题尚不清楚,只有临床经验和共识才能指导注射者。

相似文献

1
Managing spasticity with drugs.药物治疗痉挛。
Eur J Phys Rehabil Med. 2010 Sep;46(3):401-10.
2
[Pharmacology of spasticity. Does therapy remain in deep sleep?].[痉挛的药理学。治疗是否仍处于深度睡眠状态?]
Nervenarzt. 2000 Dec;71(12):927-8. doi: 10.1007/s001150050688.
3
[Treatment of spasticity].[痉挛的治疗]
Duodecim. 1999;115(8):877-85.
4
[New therapies for spastic movement disorders].[痉挛性运动障碍的新疗法]
MMW Fortschr Med. 2009 Oct;151 Suppl 3:118-22.
5
Comparative profile of tizanidine in the management of spasticity.替扎尼定在痉挛治疗中的比较概况。
Neurology. 1994 Nov;44(11 Suppl 9):S53-9.
6
Drug treatments for spasticity.痉挛的药物治疗
Ann Phys Rehabil Med. 2009 Dec;52(10):746-56. doi: 10.1016/j.rehab.2009.09.005. Epub 2009 Nov 4.
7
Anti-spasticity medications.抗痉挛药物
Saudi Med J. 2003 Jan;24(1):19-22.
8
The pharmacological management of spasticity.痉挛的药物治疗
J Neurosci Nurs. 2006 Dec;38(6):456-9.
9
[Pharmacological treatment of spasticity in multiple sclerosis].[多发性硬化症痉挛的药物治疗]
Rev Neurol (Paris). 2012 Apr;168 Suppl 3:S62-8. doi: 10.1016/S0035-3787(12)70049-8.
10
Pharmacologic treatment of spasticity in children.儿童痉挛的药物治疗。
Semin Pediatr Neurol. 2010 Dec;17(4):261-7. doi: 10.1016/j.spen.2010.10.009.

引用本文的文献

1
Spinal Cord Stimulation Immediately Improves Strength, Arm Function and Reduces Spasticity in People With Chronic Post-Stroke Upper Limb Hemiparesis.脊髓刺激可立即改善慢性中风后上肢偏瘫患者的力量、手臂功能并减轻痉挛。
Res Sq. 2025 Aug 18:rs.3.rs-7271578. doi: 10.21203/rs.3.rs-7271578/v1.
2
SPINAL CORD STIMULATION IMPROVES MOTOR FUNCTION AND SPASTICITY IN CHRONIC POST-STROKE UPPER LIMB HEMIPARESIS.脊髓刺激改善慢性卒中后上肢偏瘫的运动功能和痉挛状态。
medRxiv. 2025 Aug 6:2025.08.01.25332445. doi: 10.1101/2025.08.01.25332445.
3
Intrathecal baclofen therapy in patients with spastic paraplegia: retrospective evaluation of pretreatment drugs, test dosage, dose increments and final therapy.
鞘内注射巴氯芬治疗痉挛性截瘫患者:对治疗前用药、试验剂量、剂量递增及最终治疗的回顾性评估
Brain Spine. 2025 Jul 5;5:104323. doi: 10.1016/j.bas.2025.104323. eCollection 2025.
4
Non-Pharmacological Therapies for Post-Stroke Spastic Paralysis: A Bibliometric Analysis of Global Research from 2000 to 2024.中风后痉挛性瘫痪的非药物治疗:2000年至2024年全球研究的文献计量分析
J Multidiscip Healthc. 2024 Dec 14;17:5949-5965. doi: 10.2147/JMDH.S507752. eCollection 2024.
5
Treatment Patterns and Healthcare Costs Among Patients with Stroke and Spasticity: A 2-Year Longitudinal Study.中风与痉挛患者的治疗模式及医疗费用:一项为期两年的纵向研究。
Neurol Ther. 2025 Feb;14(1):261-278. doi: 10.1007/s40120-024-00692-9. Epub 2024 Dec 17.
6
Effect of Botulinum Toxin Injections in the Treatment of Spasticity of Different Etiologies: An Umbrella Review.肉毒杆菌毒素注射治疗不同病因痉挛的效果:一项伞状综述
Pharmaceuticals (Basel). 2024 Feb 28;17(3):310. doi: 10.3390/ph17030310.
7
The state of the art in therapeutic administration of botulinum toxin in children with cerebral palsy: an integrative review.治疗脑瘫儿童肉毒杆菌毒素的最新进展:综合评价。
Rev Paul Pediatr. 2024 Mar 25;42:e2023093. doi: 10.1590/1984-0462/2024/42/2023093. eCollection 2024.
8
Best Practice Guidelines for the Management of Patients with Post-Stroke Spasticity: A Modified Scoping Review.《脑卒中后痉挛管理患者的最佳实践指南:改良范围综述》。
Toxins (Basel). 2024 Feb 10;16(2):98. doi: 10.3390/toxins16020098.
9
Health care resource utilization and costs among patients with spasticity or cervical dystonia.痉挛或颈肌张力障碍患者的医疗资源利用和费用。
J Manag Care Spec Pharm. 2024 Jan;30(1):86-97. doi: 10.18553/jmcp.2023.22205. Epub 2023 Dec 6.
10
Botulinum Toxin Utilization, Treatment Patterns, and Healthcare Costs Among Patients with Spasticity or Cervical Dystonia in the US.肉毒毒素在美国痉挛或颈肌张力障碍患者中的应用、治疗模式和医疗保健费用。
Adv Ther. 2023 Sep;40(9):3986-4003. doi: 10.1007/s12325-023-02563-5. Epub 2023 Jul 7.